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Introduction Large scale genetic studies such as genome–wide
association studies (GWAS) in Parkinson’s disease (PD) have
revealed genetic susceptibility factors and continue to offer new
insights both into the genetics of sporadic disease and its patho-
genesis, with the potential for identiﬁcation of an at–risk popu-
lation and novel therapeutic targets. However, the methodology
importantly requires larger data sets for replication of novel
ﬁndings.
Aim To develop an independent UK–based PD DNA bank to
act as a national and international resource for large–scale
genetic studies.
Methods The study was initiated as part of an MRC–funded
fellowship in 2009 and was adopted onto the NIHR portfolio
in 2010. Patients were included if they had a clinical diagnosis
of PD. Section 30 (Mental Capacity Act 2005) approval was
also obtained to facilitate recruitment of those with diminished
capacity. Patients were excluded if they had previously donated
to another national DNA collection, such as PD GEN. Spouse/
carer controls were also recruited. 37 Centres from across the
UK took part in the study. DNA was extracted and stored at
Royal Devon and Exeter Hospital, Devon.
Results To date over 1370 patients and 530 controls have been
recruited to the study. The population characteristics of patients
are: 61.1% male, 98.1% white, 18.6% positive family history,
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mean age 70.6 yrs (range 40–98), mean disease duration 5.6 yrs
(range 0–49).
Conclusions We have established an independent PD DNA
Bank which will have reached its target of 1500 patient samples
by April 2013. This sample bank will be similar in size and com-
position to other national collections such as PD GEN and will
act as a valuable resource locally, nationally and for the global
PD research community. Its establishment within 3 years is a tes-
timony to the efﬁcient working of the clinical research networks
within the UK.
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